Grønbæk, H., Flyvbjerg, A., Mellemkjær, L., Tjønneland, A., Christensen, J.
, Sørensen, H. T. & Overvad, K. (2004).
Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
Cancer Epidemiology, Biomarkers & Prevention,
13, 1759-1764.
E. Allen, N., Key, T. J., Appleby, P. N., Travis, R. C., Roddam, A. W., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., Boeing, H., Føns Johnsen, N., Tjønneland, A.
, Grønbæk, H., Overvad, K., Kiemeney, L., Bueno-de-Mesquita, H. B., Bingham, S., Tee Khaw, K. ... Kaaks, R. (2007).
Serum insulin-like growth factor (IGF)- I and IGF-binding protein-3 concentrations and prostate cancer risk: Results from the European prospective investigation into cancer and nutrition.
Cancer Epidemiology, Biomarkers & Prevention,
16(6), 1121-1127.
Peeters, PHM., Lukanova, A., Allen, N., Berrino, F., Key, T., Dossus, L., Rinaldi, S., vanGils, CH., Bueno-de-Mesquita, HB., Boeing, H., Schulz, M., Chang-Claude, J., Linseisen, J., Panico, S., Sacerdote, C., Palli, D., Tumino, R., Trichopoulou, A., Trichopolos, D. ... Kaaks, R. (2007).
Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
Endocrine - Related Cancer,
14(1), 81-90.
Allen, NE., Key, TJ., Appleby, PN., Travis, RC., Roddam, AW., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., Boeing, H., Johnsen, NF., Tjønneland, A., Gronbaek, H.
, Overvad, K., Kiemeney, L., Bueno-de-Mesquita, HB., Bingham, S., Khaw, K. T. ... Kaaks, R. (2007).
Serum IGF-I and IGFBP-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Cancer Epidemiology, Biomarkers, and Prevention,
16, 1121-7.
Würtz, A. M. L., Tjønneland, A., Christensen, J., Dragsted, L. O., Aarestrup, J., Kyrø, C.
, Overvad, K. & Olsen, A. V. (2012).
Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
Cancer Causes & Control,
23(10), 1711-20.
https://doi.org/10.1007/s10552-012-0050-7
Kong, S. Y., Tran, H. Q., Gewirtz, A. T., McKeown-Eyssen, G., Fedirko, V., Romieu, I., Tjønneland, A.
, Olsen, A., Overvad, K., Boutron-Ruault, M.-C., Bastide, N., Affret, A., Kühn, T., Kaaks, R., Boeing, H., Aleksandrova, K., Trichopoulou, A., Kritikou, M., Vasilopoulou, E. ... Jenab, M. (2016).
Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
Cancer Epidemiology, Biomarkers & Prevention,
25(2), 291-301.
https://doi.org/10.1158/1055-9965.EPI-15-0798
Verheus, M., Peeters, PH., Rinaldi, S., Dossus, L., Biessy, C.
, Olsen, A. V., Tjønneland, A.
, Overvad, K., Jeppesen, M., Clavel-Chapelon, F., Tehard, B., Nagel, G., Linseisen, J., Boeing, H., Lahmann, PH., Arvaniti, A., Psaltopoulou, T., Palli, D., Tumino, R. ... Kaaks, R. (2006).
Serum C-peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC).
International Journal of Cancer,
119, 659-67.